Linden Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
AA
LP
TCM
KIM
PAMP
AIMCA
RCM
Linden Advisors's TDAC Position: Q1 2026 in Review
Linden Advisors held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 600,000 shares worth $6.34M. The position accounts for 0.04% of the portfolio, ranked #253.
Linden Advisors first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- Linden Advisors held 600,000 shares of Translational Development Acquisition Corp worth $6.34M as of Q1 2026.
- Linden Advisors left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
- Translational Development Acquisition Corp made up 0.04% of Linden Advisors's portfolio in Q1 2026, its #253 holding.
- Linden Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on Linden Advisors's 13F filing for Q1 2026, filed 15 May 2026.